These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38646011)

  • 1. Synthetic protein protease sensor platform.
    Devoy C; Flores Bueso Y; Buckley S; Walker S; Tangney M
    Front Bioeng Biotechnol; 2024; 12():1347953. PubMed ID: 38646011
    [No Abstract]   [Full Text] [Related]  

  • 2. Covalent immobilization of tobacco-etch-virus NIa protease: a useful tool for cleavage of the histidine tag of recombinant proteins.
    Puhl AC; Giacomini C; Irazoqui G; Batista-Viera F; Villarino A; Terenzi H
    Biotechnol Appl Biochem; 2009 May; 53(Pt 3):165-74. PubMed ID: 18937642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-peptide monoclonal antibody recognizing the tobacco etch virus protease-cleavage sequence and its application to a tandem tagging system.
    Tabata S; Kitago Y; Fujii Y; Mihara E; Tamura-Kawakami K; Norioka N; Takahashi K; Kaneko MK; Kato Y; Takagi J
    Protein Expr Purif; 2018 Jul; 147():94-99. PubMed ID: 29550370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence dequenching assay for the activity of TEV protease.
    Paththamperuma C; Page RC
    Anal Biochem; 2022 Dec; 659():114954. PubMed ID: 36265691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.
    Begum F; Srivastava AK; Tripathi PP; Ray U
    J Med Virol; 2023 May; 95(5):e28796. PubMed ID: 37218551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant fusion protein-based, fluorescent protease assay for high throughput-compatible substrate screening.
    Bozóki B; Gazda L; Tóth F; Miczi M; Mótyán JA; Tőzsér J
    Anal Biochem; 2018 Jan; 540-541():52-63. PubMed ID: 29122614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation.
    Bozóki B; Mótyán JA; Miczi M; Gazda LD; Tőzsér J
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30735187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent and non-covalent strategies for the immobilization of Tobacco Etch Virus protease (TEVp) on superparamagnetic nanoparticles.
    Norris JL; Patel T; Dasari AKR; Cope TA; Lim KH; Hughes RM
    J Biotechnol; 2020 Oct; 322():1-9. PubMed ID: 32619644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera.
    Jairajpuri MA; Ansari S
    Clin Sci (Lond); 2020 Sep; 134(17):2235-2241. PubMed ID: 32869854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation regulates proteolytic efficiency of TEV protease detected by a 5(6)-carboxyfluorescein-pyrene based fluorescent sensor.
    He YH; Li YM; Chen YX
    Talanta; 2016 Apr; 150():340-5. PubMed ID: 26838417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of C-terminal tag sequences on domain antibodies purified from E. coli supernatant.
    Lykkemark S; Mandrup OA; Friis NA; Kristensen P
    MAbs; 2014; 6(6):1551-9. PubMed ID: 25426869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of protein complexes of defined subunit stoichiometry using a set of orthogonal, tag-cleaving proteases.
    Frey S; Görlich D
    J Chromatogr A; 2014 Apr; 1337():106-15. PubMed ID: 24636567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a tag-free plant-made interferon gamma production system with improved therapeutic efficacy against viruses.
    Jiang MC; Hsu WL; Tseng CY; Lin NS; Hsu YH; Hu CC
    Front Bioeng Biotechnol; 2023; 11():1341340. PubMed ID: 38274005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new fusion protein platform for quantitatively measuring activity of multiple proteases.
    Zhou C; Yan Y; Fang J; Cheng B; Fan J
    Microb Cell Fact; 2014 Mar; 13(1):44. PubMed ID: 24649897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TEV protease cleavage in generation of artificial substrate proteins bearing neo-N-termini.
    Winckler LI; Dissmeyer N
    Methods Enzymol; 2023; 686():125-141. PubMed ID: 37532397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.
    Matveev EV; Ponomarev GV; Kazanov MD
    Microbiol Spectr; 2024 Feb; 12(2):e0353023. PubMed ID: 38189333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies.
    Cantrell MS; Wall JD; Pu X; Turner M; Woodbury L; Fujise K; McDougal OM; Warner LR
    Protein Expr Purif; 2022 Jan; 189():105989. PubMed ID: 34626801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific and efficient cleavage of fusion proteins by recombinant plum pox virus NIa protease.
    Zheng N; Pérez Jde J; Zhang Z; Domínguez E; Garcia JA; Xie Q
    Protein Expr Purif; 2008 Feb; 57(2):153-62. PubMed ID: 18024078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immobilization of tobacco etch virus (TEV) protease on a high surface area protein nanofibril scaffold.
    Raynes JK; Domigan LJ; Pearce FG; Gerrard JA
    Biotechnol Prog; 2018 Nov; 34(6):1506-1512. PubMed ID: 29882251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved solubility of TEV protease by directed evolution.
    van den Berg S; Löfdahl PA; Härd T; Berglund H
    J Biotechnol; 2006 Feb; 121(3):291-8. PubMed ID: 16150509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.